AlternativeMed
ancient wisdom · Remedy

Shensong Yangxin Capsule

Shensong Yangxin Capsule. Chinese patent medicines. For: It is used for the treatment of premature ventricular contractions of coronary heart disease, which is a syndrome of deficiency of both qi and yin, heart and collateral stasis, symptomatic palpit

📜 Names
Pinyin Name
Shensong Yangxin Jiaonang
中文名 (Chinese)
参松养心胶囊
English Name
Shensong Yangxin Capsule
💊 Form & Use
Category
Chinese patent medicines
Dosage Form
胶囊剂 (Capsule)
Administration
Oral
Source / 出处
Chinese Pharmacopoeia 2020 edition
🌿 Composition — Clickable herb chips
Herbs (Pinyin)
Ren Shen 、 Mai Dong 、 Shan Zhu Yu 、 Sang Ji Sheng 、 Tu Bie Chong 、 Chi Shao 、 Huang Lian 、 Nan Wu Wei Zi 、 Long Gu Deng Yao
🩺 Syndromes & Indications
Syndromes (中文)
益气养阴,活血通络,清心安神
Indications (中文)
用于治疗冠心病室性早搏属气阴两虚,心络瘀阻证,症见心悸不安,气短乏力,动则加剧,胸部闷痛,失眠多梦,盗汗,神倦懒言
Indications (English)
It is used for the treatment of premature ventricular contractions of coronary heart disease, which is a syndrome of deficiency of both qi and yin, heart and collateral stasis, symptomatic palpitations, shortness of breath, fatigue, aggravated movement, chest pain, insomnia, dreams, night sweats, tiredness and laziness.
0
Clinical Trials
11
Meta-Analyses
1
PubMed References
📋 Sample Trials
None linked yet.
📊 Sample Meta-Analyses
CRD42020151373
Different types of traditional Chinese patent medicine for ventricular premature contraction:a network Meta analysis
Premature ventricular contractions (PVC) are a common, age-related , form of dys
CRD42020183917
Efficacy of Shensongyangxin Capsule for bradycardia: A Meta-analysis of 32 Randomized Controlled Trials
Bradycardia is a commonly observed arrhythmia, and mainly treated by pacemaker i
CRD42020196681
The clinical efficacy and safety of Shensongyangxin capsule-amiodarone in the treatment of heart failure with ventricular arrhythmia: a meta-analysis of randomized controlled trials
Heart failure (HF) is the end stage of various heart diseases, affecting 1% - 2%
CRD42020196689
Clinical Efficacy and Safety of Shensong Yangxin Capsule-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Meta-analysis of Randomized Controlled Trials
Heart failure (HF) is the end stage of various heart diseases, affecting 1% - 2%
CRD42021229693
A network meta-analysis of the clinical efficacy and safety of thirteen therapies for patients with coronary heart disease and arrhythmia.
CRD42021281344
The efficacy of combined Shensongyangxin capsule and Amiodaron on the treatments of chronic heart failure: A systematic review and meta-analysis
it provides a systematic review and meta-analysis on the effects of combined She
📚 Sample References
PMID 25267579
Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling
J Ethnopharmacol · 2014
🏥 Indications — click any to find related diseases